ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,613,000 | +3.9% | 34,825 | -45.3% | 0.00% | 0.0% |
Q1 2019 | $1,553,000 | +183.4% | 63,683 | +65.7% | 0.00% | +100.0% |
Q4 2018 | $548,000 | +18166.7% | 38,444 | +14191.4% | 0.00% | – |
Q4 2017 | $3,000 | -66.7% | 269 | -64.9% | 0.00% | – |
Q3 2017 | $9,000 | +50.0% | 767 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -14.3% | 767 | 0.0% | 0.00% | – |
Q1 2017 | $7,000 | +16.7% | 767 | -0.4% | 0.00% | – |
Q4 2016 | $6,000 | +100.0% | 770 | -26.7% | 0.00% | – |
Q1 2016 | $3,000 | -40.0% | 1,050 | -0.3% | 0.00% | – |
Q3 2015 | $5,000 | -28.6% | 1,053 | -23.9% | 0.00% | – |
Q4 2014 | $7,000 | +16.7% | 1,384 | -11.3% | 0.00% | – |
Q3 2014 | $6,000 | -14.3% | 1,560 | 0.0% | 0.00% | – |
Q2 2014 | $7,000 | -12.5% | 1,560 | -7.0% | 0.00% | – |
Q1 2014 | $8,000 | 0.0% | 1,678 | 0.0% | 0.00% | – |
Q4 2013 | $8,000 | -27.3% | 1,678 | -1.9% | 0.00% | – |
Q3 2013 | $11,000 | – | 1,711 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |